Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Solana CompanyNASDAQ: HSDT
Gross Profit · Q1 FY2026 · quarter ended Mar 2026
Gross profit turns positive
Q1 FY2026 gross profit was $3.44M, compared with -$72K a year earlier. Trailing-twelve-month gross profit was $9.03M. Over 3 fiscal years it compounded at +157.3% a year.
Context
- Gross profit amounted to 91.7% of revenue in FY2025, up 79.8 pp from a year earlier.
- Gross profit increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly gross profit holds near $3.44M or moves back toward the trailing-twelve-month quarterly average of $2.26M.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 5.52M USD
- Year-over-year change
- +8998.4%
- 4-year CAGR
- +122.8%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.52M | +8998.4% |
| FY2024 | 2024-12-31 | (62K) | -201.6% |
| FY2023 | 2023-12-31 | 61K | -81.2% |
| FY2022 | 2022-12-31 | 324K | +44.6% |
| FY2021 | 2021-12-31 | 224K | — |
Gross Profit vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's LTM Mar 2026 gross profit of $9.03M is the 9th highest of the 11 companies compared; the peer median is $42.98M.
- Its year-over-year change of +6284.9% is the highest of 11, against a peer median of +13.0%.
- Gross profit amounts to 94.2% of revenue for HSDT, versus a peer median of 73.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $171.29M | +9.3% | +2.6% | 48.7% | |
| LTM Mar 2026 | $80.81M | +10.6% | +9.9% | 56.7% | |
| LTM Mar 2026 | $63.93M | -19.3% | +12.6% | 44.1% | |
| LTM Mar 2026 | $56.28M | +18.1% | +16.7% | 78.4% | |
| LTM Mar 2026 | $47.78M | +15.4% | +37.9% | 40.6% | |
| LTM Mar 2026 | $38.18M | +38.8% | +55.6% | 85.1% | |
| LTM Mar 2026 | $33.55M | +21.0% | +39.9% | 75.7% | |
| LTM Mar 2026 | $13.41M | +43.6% | +56.6% | 71.1% | |
| LTM Mar 2026 | $9.03M | +6284.9% | +157.3% | 94.2% | |
| LTM Mar 2026 | -$3.03M | -150.0% | — | 489.8% | |
| LTM Dec 2025 | -$12.79M | -19.4% | — | 98.2% | |
| Peer median (excluding HSDT) | $42.98M | +13.0% | +27.3% | 73.4% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 522K | 787K | 644K | 520K | 6.02M |
| Cost of Revenue | 298K | 463K | 583K | 582K | 500K |
| Gross Profit | 224K | 324K | 61K | (62K) | 5.52M |
| Gross Margin | 42.9% | 41.2% | 9.5% | -11.9% | 91.7% |
| Research & Development | 5.99M | 4.26M | 2.94M | 3.66M | 3.51M |
| Selling, General & Admin | 12.18M | 10.64M | 9.27M | 10.12M | 23.13M |
| Operating Expenses | 18.37M | 15.84M | 12.49M | 13.84M | 26.64M |
| Depreciation & Amortization | 312K | 255K | 162K | 60K | 680K |
| EBITDA | (17.82M) | (14.5M) | (12.11M) | (13.8M) | (39.58M) |
| EBITDA Margin | -3413.8% | -1842.9% | -1880.0% | -2654.4% | -657.7% |
| Operating Income | (18.14M) | (15.52M) | (12.43M) | (13.9M) | (21.12M) |
| Operating Margin | -3475.5% | -1971.5% | -1929.8% | -2673.7% | -351.0% |
| Interest Income | 0 | 0 | 257K | 0 | 0 |
| Interest Expense | 0 | 834K | 0 | 17K | 635K |
| Other Income / Expenses | 10K | 1.44M | 3.58M | 2.16M | (19.77M) |
| Income Before Tax | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Pre-Tax Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Net Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| EPS (Basic) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| EPS (Diluted) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| Weighted Avg Shares | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
| Weighted Avg Shares (Diluted) | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.